Cosmo Pharmaceuticals N.V. carries a market capitalization of 1.24B, placing it among publicly traded companies globally.
| Market Cap | 1.24B |
| Enterprise Value | N/A |
Cosmo Pharmaceuticals N.V.'s stock has declined approximately -3.50667% over the past 52 weeks. The 50-day moving average sits at 76.73, while the 200-day moving average is 108.23.
| Beta (5Y) | N/A |
| 52-Week Price Change | -3.50667% |
| 50-Day Moving Average | 76.73 |
| 200-Day Moving Average | 108.23 |
| Average Volume (20 Days) | N/A |